comparemela.com
Home
Live Updates
Laekna, a Biotechnology Company in China, Listed on the Main Board of the Hong Kong Stock Exchange : comparemela.com
Laekna, a Biotechnology Company in China, Listed on the Main Board of the Hong Kong Stock Exchange
HONG KONG, June 29, 2023 - (ACN Newswire) - A biotechnology company in China - Laekna, Inc. (HKG: 2105), today listed on the Main Board of The Stock Exchange of Hong Kong Limited (the Hong Kong Stock
Related Keywords
Hong Kong ,
China ,
United States ,
Yong Yue ,
Jiangsu ,
Chris Lu ,
Lu Chris Xiangyang ,
Justin Gu ,
Laekna International Offering ,
Alumni Of Nankai University ,
Industry Investment Fund ,
Core Product Of The Company ,
Laekna Inc ,
Seasoned Core Management Team Members ,
Novartis ,
Yuyao Yangming Equity Investment Fund Co Ltd ,
Orbimed Healthcare Fund Management ,
China Novartis Institute For Biomedical Research ,
Company Core Products ,
Main Board ,
Stock Exchange ,
Hong Kong Limited ,
Hong Kong Stock Exchange ,
Chief Executive Officer ,
Core Products ,
Core Product ,
International Offering ,
Hong Kong Offering ,
Global Leader ,
Multi Regional Clinical Trials ,
Core Management Team Members ,
Nankai University ,
Have An Extensive History ,
Chief Medical Officer ,
Chief Scientific Officer ,
China Novartis Institute ,
Future Industry Investment Fund ,
Limited Partnership ,
Orbimed Asia Partners ,
comparemela.com © 2020. All Rights Reserved.